SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001493152-22-017739
Filing Date
2022-06-24
Accepted
2022-06-24 17:17:07
Documents
13
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 form10-ka.htm   iXBRL 10-K/A 109268
2 ex31-1.htm EX-31.1 4932
  Complete submission text file 0001493152-22-017739.txt   335809

Data Files

Seq Description Document Type Size
3 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT glsi-20211231.xsd EX-101.SCH 3072
4 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT glsi-20211231_lab.xml EX-101.LAB 35941
5 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT glsi-20211231_pre.xml EX-101.PRE 23644
7 EXTRACTED XBRL INSTANCE DOCUMENT form10-ka_htm.xml XML 6404
Mailing Address 3992 BLUEBONNET DR, BUILDING 14 STAFFORD TX 77477
Business Address 3992 BLUEBONNET DR, BUILDING 14 STAFFORD TX 77477 203-434-3290
Greenwich LifeSciences, Inc. (Filer) CIK: 0001799788 (see all company filings)

IRS No.: 205473709 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-39555 | Film No.: 221040934
SIC: 2834 Pharmaceutical Preparations